Emerging legal issues relating to advanced therapies: a European perspective
31.10.2008 | Life Sciences & Healthcare
Artikel in SCRIPT Drug Market Developments vom August 2008 von Dr. Wolfgang Rehmann, Partner IP München und Gareth Morgan, Partner IP London
Anwälte Dr. Wolfgang Rehmann
